source
- AUA and SUO Issue 2026 Update to Advanced Prostate Cancer GuidelineThe American Urological Association (AUA) and the Society of Urologic Oncology (SUO) have released an amendment to their Advanced Prostate Cancer Guideline for 2026. The update revises recommendat…
- Delayed and re-emergent immune-related adverse events can persist years after melanoma checkpoint therapy, says expertDr. Michael A. Postow, chief of the Melanoma Service at Memorial Sloan Kettering Cancer Center, explained that immune checkpoint inhibitors (ICIs) for melanoma have a distinct toxicity profile comp…